Scott M. Lippman, MD, former chair of the Department of Thoracic/Head and Neck Medical Oncology and professor of cancer medicine and cancer prevention at The University of Texas MD Anderson Cancer Center, started as director of Moores Cancer Center at the University of California, San Diego, on May 1. He succeeds Dennis A. Carson, MD, who served as director from 2003 to 2011, and Thomas Kipps, MD, PhD, who served as interim director since 2011.
Lippman's major fields of research are translational and molecular studies of cancer risk, molecularly targeted drug development, and personalized therapy. He has been a leader in clinical and translational research planning and development through the National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program and currently sits on the NIH Clinical Trials/Translational Research Advisory Committee.
At Moores, an NCI-designated comprehensive cancer center, Lippman plans to expand the portfolio of clinical and translational research, ramp up research-driven cancer therapy, and build on prevention programs.
Stephen D. Nimer, MD, started his new position as the director of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine in Florida on May 1. An internationally recognized expert on leukemia and stem cell transplantation, Nimer was previously the vice chair for faculty development at Memorial Sloan-Kettering Cancer Center's (MSKCC) Department of Medicine. [Photo courtesy of Kikor.com.]
At Sylvester, Nimer plans to develop and expand programs for breast, lung, prostate, and blood cancers, and recruit experts in bone marrow transplantation, mouse models of human cancer, and molecular diagnostics.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.